Toxicología en microdosis
Septiembre 2, 2025
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Summary Background: Psilocybin is a serotonin receptor agonist that occurs naturally in some mushroom species. Recent studies have assessed the therapeutic potential of psilocybin for various conditions, including end-of-life depression, anxiety, and treatment-resistant depression...
Leer más →